Predictions
Compagnie Financière Richemont SA ADR
Start price
Target price
Perf. (%)
€6.50
06.11.20
06.11.20
€6.00
2.97%
10.11.20
10.11.20
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
NIO Inc. ADR
Start price
Target price
Perf. (%)
€37.30
06.11.20
06.11.20
€40.00
7.51%
12.11.20
12.11.20
Innovative
EBIT growth >5% per year expected
Top 10 in its market
Known brand
Farfetch Ltd
Start price
Target price
Perf. (%)
€35.80
06.11.20
06.11.20
€40.00
5.03%
11.11.20
11.11.20
Top 10 in its market
Known brand
Probably not worthwhile Investment
Low dividend yield expected
Ose Pharma International S.A.
Start price
Target price
Perf. (%)
€9.36
06.11.20
06.11.20
€14.00
06.11.21
06.11.21
23.50%
21.09.21
21.09.21
Could be worthwhile Investment >10% per year
Amazon.com Inc.
Start price
Target price
Perf. (%)
€139.78
06.11.20
06.11.20
€160.00
06.11.21
06.11.21
12.75%
08.07.21
08.07.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
T-Mobile US Inc.
Start price
Target price
Perf. (%)
€104.52
06.11.20
06.11.20
€100.00
2.26%
12.11.20
12.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Valuable balance sheet
ROE higher than 10% per year
Sfc Energy AG
Start price
Target price
Perf. (%)
€14.64
05.11.20
05.11.20
-
05.11.21
05.11.21
14.21%
18.01.21
18.01.21
Outdated or very high risk business model
High risks for its business
Risky Investment
NIO Inc. ADR
Start price
Target price
Perf. (%)
€34.70
05.11.20
05.11.20
€40.00
7.49%
06.11.20
06.11.20
Innovative
EBIT growth >5% per year expected
Top 10 in its market
Known brand
Cliq Digital AG
Start price
Target price
Perf. (%)
€18.30
05.11.20
05.11.20
€20.00
3.83%
17.11.20
17.11.20
Undervalued
ROE higher than 15% per year
Revenue growth > 30% per year expected
Small Risks for its business
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.50
05.11.20
05.11.20
-
05.11.21
05.11.21
47.44%
06.11.21
06.11.21
Bitcoin Group SE
Start price
Target price
Perf. (%)
€29.25
05.11.20
05.11.20
€50.00
05.11.21
05.11.21
81.88%
06.11.21
06.11.21
Revenue growth >5% per year expected
positive Cash Flow expected
Standard Investments for future growth
Risky balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€77.54
05.11.20
05.11.20
-
05.11.21
05.11.21
20.98%
27.11.20
27.11.20
Rising EBIT margin expected
Good rating
High Investments for future growth
Valuable balance sheet
Invesco Ltd.
Start price
Target price
Perf. (%)
€12.21
05.11.20
05.11.20
-
05.11.21
05.11.21
49.23%
03.02.21
03.02.21
Future proof or reliable business model
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Below average Management
Ferrari NV
Start price
Target price
Perf. (%)
€173.50
05.11.20
05.11.20
€185.00
-0.23%
06.11.20
06.11.20
Revenue growth > 30% per year expected
Undervalued
Very Future proof/growth oriented business model
Well known brand
Cassava Sciences Inc.
Start price
Target price
Perf. (%)
€9.05
05.11.20
05.11.20
-
05.11.21
05.11.21
728.91%
06.11.21
06.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€247.50
05.11.20
05.11.20
€255.00
-8.42%
11.12.20
11.12.20
Top 10 in its market
Revenue growth >5% per year expected
Good rating
Some uniques
Sio Gene Therapies Inc.
Start price
Target price
Perf. (%)
€1.87
05.11.20
05.11.20
€2.00
05.11.21
05.11.21
-7.97%
06.11.21
06.11.21
Future proof or reliable business model
Applied DNA Sciences Inc.
Start price
Target price
Perf. (%)
€5.90
05.11.20
05.11.20
€20.00
05.11.21
05.11.21
-17.29%
06.11.21
06.11.21
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Aphria Inc.
Start price
Target price
Perf. (%)
€4.70
05.11.20
05.11.20
-
05.11.21
05.11.21
170.32%
06.11.21
06.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Delivery Hero SE
Start price
Target price
Perf. (%)
€112.60
05.11.20
05.11.20
€120.00
2.98%
16.12.20
16.12.20
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
EOG Resources Inc.
Start price
Target price
Perf. (%)
€30.40
05.11.20
05.11.20
-
05.11.21
05.11.21
57.24%
09.01.21
09.01.21
High dividend yield expected
Sustainability is little important
Higher risks for its business
Significant cyclical dependencies
Cadence Design Systems
Start price
Target price
Perf. (%)
€103.62
05.11.20
05.11.20
€150.00
05.11.21
05.11.21
48.54%
06.11.21
06.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
ProSiebenSat.1 Media SE
Start price
Target price
Perf. (%)
€9.99
04.11.20
04.11.20
-
27.08%
25.11.20
25.11.20
Risky Investment
Jumia Technologies AG
Start price
Target price
Perf. (%)
€15.20
04.11.20
04.11.20
€49.00
04.11.21
04.11.21
59.87%
19.04.21
19.04.21
Good rating
Standard Investments for future growth
High valuation
Very low/no dividend yield expected
Washington Prime Group Inc.
Start price
Target price
Perf. (%)
€4.76
04.11.20
04.11.20
€6.30
04.11.21
04.11.21
-11.41%
06.11.20
06.11.20
Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation